Learning Hub: Webinars

Jets Partnered With QuidelOrtho and American Red Cross to Host Holiday Blood Drive

The New York Jets and QuidelOrtho Corporation ("QuidelOrtho") hosted a blood drive with the American Red Cross on Monday, December 12. Staff members of the Jets and QuidelOrtho joined local community members to donate blood this holiday season. The blood drive collected 27 pints of blood, which can help save approximately 80 lives.

Ortho® Workstation Earns AABB Quality Seal

First product of its kind awarded by the AABB’s Standards-Compliant Product Program

Ortho® Workstation Earns AABB Quality Seal

First product of its kind awarded by the AABB’s Standards-Compliant Product Program

QuidelOrtho Joins Alliance for a Strong Blood Supply Launched by Association for the Advancement of Blood & Biotherapies

QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho” or the “Company”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it is joining the Alliance for a Strong Blood Supply (the “Alliance”). The Alliance is a coalition founded by the Association for the Advancement of Blood & Biotherapies (“AABB”) that includes a group of partner organizations committed to ensuring sufficient blood is available for all patients during the pandemic and beyond.

Jets Partnered With QuidelOrtho and American Red Cross to Host Holiday Blood Drive

The New York Jets and QuidelOrtho Corporation ("QuidelOrtho") hosted a blood drive with the American Red Cross on Monday, December 12. Staff members of the Jets and QuidelOrtho joined local community members to donate blood this holiday season. The blood drive collected 27 pints of blood, which can help save approximately 80 lives.

Ortho® Workstation Earns AABB Quality Seal

First product of its kind awarded by the AABB’s Standards-Compliant Product Program

Ortho® Workstation Earns AABB Quality Seal

First product of its kind awarded by the AABB’s Standards-Compliant Product Program

QuidelOrtho Joins Alliance for a Strong Blood Supply Launched by Association for the Advancement of Blood & Biotherapies

QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho” or the “Company”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it is joining the Alliance for a Strong Blood Supply (the “Alliance”). The Alliance is a coalition founded by the Association for the Advancement of Blood & Biotherapies (“AABB”) that includes a group of partner organizations committed to ensuring sufficient blood is available for all patients during the pandemic and beyond.

QuidelOrtho provides easier, faster test results with new molecular platform

In this Repertoire Podcast, Repertoire Magazine publisher Scott Adams is joined by Tammi Ranalli, the Senior Vice President of Molecular Diagnostics for the QuidelOrtho Corporation to discuss QuidelOrtho’s new molecular diagnostic innovation, the Savanna. “This has really been an over 10-year labor of love for me,” Ranalli said about the new cartridge-based molecular platform.

Quidel Named First Partner at SDSU Mission Valley Innovation District, Founding Partner at Snapdragon Stadium

San Diego State University announced today the execution of partnership agreements with Quidel Corporation (“Quidel”), a subsidiary of QuidelOrtho Corporation (NASDAQ: QDEL) and a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, that will make Quidel the first partner in SDSU Mission Valley’s Innovation District and a Founding Partner at SDSU’s Snapdragon Stadium, the new home of Aztec football.

Opinion: Here’s how San Diego biotech helped fight the COVID-19 pandemic

Countless academic and research institutions, companies and organizations working on life sciences and biotechnology are woven into the city’s fabric

2022 AACC Annual Scientific Meeting + Clinical Lab Expo

Quidel Corporation and Ortho Clinical Diagnostics to exhibit at the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo

How Quidel Navigated COVID-19: A conversation with Quidel President and CEO Doug Bryant

How Quidel Navigated COVID-19: A conversation with Quidel President and CEO Doug Bryant

Ortho Recently Featured as a Corporate Partner in the AABB Monthly Magazine

Ortho Recently Featured as a Corporate Partner in the AABB Monthly Magazine

Maximizing the Benefits of COVID-19 Vaccines With the Right Serological Tests

Ortho’s CE-Marked VITROS® SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals

North America Downloadable Resources

What is SARS-CoV-2 (Coronavirus)?

SARS-CoV-2 Total Assay Recently Validated by the Centre National de Référence (Institut Pasteur et Hospices Civils de Lyon) with 100% specificity

e-Connectivity® Technology for ORTHO VISION® Analyzers

How Ortho’s VITROS® XT Solutions Were Inspired by an Important Constituency: Our Customers

Why the Laboratory Is at the Forefront of the Global Fight Against HIV

Ortho Clinical Brings New Tech to World of Medical Diagnostics

Diagnostics’ Waterless Wave: An Ortho Customer Case Study

Ortho Gets CE Mark for Slides That Run 2 IVD Tests Off a Single Blood Sample

Ortho Clinical Diagnostics Revolutionizes Lab Tech